Micro-immunotherapeutic agent 2LXFS

{
  "id": "MLC-T-ONC-015170",
  "term": "Micro-immunotherapeutic agent 2LXFS",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable micro-immunotherapeutic agent composed of various immune substances in diluted doses, with potential immunomodulating, anti-infective and anti-viral activities. The micro-immunotherapeutic agent 2LXFS contains various recombinant immunological active ingredients in low concentrations, including, but not limited to, cytokines, such as interleukin-1 (IL-1), IL-2, interferon alpha (IFN-a), IFN gamma (IFN-g), tumor necrosis factor alpha (TNF-a), and specific nucleic acids (SNAs) that are small synthesized oligonucleotides that prevent gene expression, such as the genes involved in viral replication. Upon oral administration of micro-immunotherapeutic agent 2LXFS, the active ingredients may help balance, restore and/or modulate the immune system. This may restore an adequate, re-adjusted anti-antiviral immune response. The formulation within each capsule is different and the levels of concentration of each substance can vary to allow stimulation, modulation and/or inhibition of the immune response in order to mimic what would naturally occur within the body. Therefore, the capsules are administered in a specific order.",
  "synonyms": [
    "2LXFS"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/micro-immunotherapeutic-agent-2lxfs/"
}